Literature DB >> 12854082

Prematurity is the major risk factor for late-onset group B streptococcus disease.

Feng-Ying C Lin1, Leonard E Weisman, James Troendle, Karen Adams.   

Abstract

A case-control study was conducted in the greater Houston area to determine risk factors for late-onset group B streptococcus (GBS) disease (onset of disease or first positive culture between 7 and 180 days after birth). Characteristics of 122 case patients diagnosed during 1995-2000 were compared with control subjects matched for birth hospital and date of birth. Half the case patients were preterm infants, 84% of whom were born at <34 weeks of gestation. The risk for late-onset GBS disease increased by a factor of 1.34 (95% confidence interval [CI], 1.15-1.56) for each week of decreasing gestation, by 3.70 (95% CI, 1.35-10.1) for infants of black mothers, and by 4.15 (95% CI, 1.27-13.60) for infants of mothers with a positive GBS screening. These risk factors are similar to that of early-onset GBS disease. However, prematurity is the major risk factor for late-onset GBS disease.

Entities:  

Mesh:

Year:  2003        PMID: 12854082     DOI: 10.1086/376457

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.

Authors:  Jillian Pintye; Babette Saltzman; Elizabeth Wolf; Claudia S Crowell
Journal:  J Pediatric Infect Dis Soc       Date:  2015-10-12       Impact factor: 3.164

Review 2.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

3.  Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.

Authors:  M Trijbels-Smeulders; G A de Jonge; P C M Pasker-de Jong; L J Gerards; A H Adriaanse; R A van Lingen; L A A Kollée
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-16       Impact factor: 5.747

4.  Enhanced Postnatal Acquisition of Hypervirulent Group B Streptococcus.

Authors:  Adam J Ratner
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

Review 5.  Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.

Authors:  Michelle L Korir; Shannon D Manning; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 6.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 8.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05

9.  Synchronous recurrence of group B streptococcal late-onset sepsis in twins.

Authors:  Roland Elling; Markus Hufnagel; Aruni de Zoysa; Fabian Lander; Katharina Zumstein; Marcus Krueger; Philipp Henneke
Journal:  Pediatrics       Date:  2014-04-07       Impact factor: 7.124

Review 10.  Understanding the regulation of Group B Streptococcal virulence factors.

Authors:  Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.